Metastatic Colorectal Cancers Active Not Recruiting Phase 2 Trials for Erlotinib (DB00530)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02723578Pemetrexed and Erlotinib for Metastatic Colorectal CancerTreatment